Showing results (2411-2420 of 2,573) with videos related to

Sort By:
Pageof 258
Human Gene Therapy|August 19, 2023
Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase DeficiencyNeel Mehta, Rénald Gilbert, Parminder S Chahal, et al.
The American Journal of Sports Medicine|August 8, 2023
Association Between Symptom Cluster Endorsement at Initiation of a Graduated Return-to-Activity Protocol and Time to Return to Unrestricted Activity After Concussion in United States Service Academy CadetsMichael J Aderman, Benjamin L Brett, Jeremy D Ross, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
Molecular Cancer Therapeutics|June 19, 2003
Evaluation of cancer therapy using diffusion magnetic resonance imagingBrian D Ross, Bradford A Moffat, Theodore S Lawrence, et al.
Cancer Discovery|March 28, 2013
Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancerJim Sang, Jaime Acquaviva, Julie C Friedland, et al.
Nature Communications|August 17, 2022
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapyBrian D Ross, Youngsoon Jang, Amanda Welton, et al.
Translational Oncology|November 13, 2014
A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancerKyle C Cuneo, Thomas L Chenevert, Edgar Ben-Josef, et al.
Scientific Reports|June 9, 2017
CT-Based Local Distribution Metric Improves Characterization of COPDBenjamin A Hoff, Esther Pompe, Stefanie Galbán, et al.
The Lancet. Oncology|December 29, 2015
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trialAlice T Shaw, Leena Gandhi, Shirish Gadgeel, et al.
ESMO Open|December 7, 2017
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancerFiona Blackhall, D Ross Camidge, Alice T Shaw, et al.
Pageof 258